☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Inventisbio
Betta Pharma Licenses Inventisbio's D-0316 to Treat Non-Small Cell Lung Cancer (NSCLC)
December 31, 2018
Load more...
Back to Home